Utama › Karsinoma Nasofaring › Missouri
Kajian klinikal Karsinoma Nasofaring di Missouri
3 kajian untuk Karsinoma Nasofaring sedang mencari peserta di lokasi di Missouri.
Teks kajian rasmi (Bahasa Inggeris)
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06029270A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
- Children's Mercy Hospitals and Clinics, Kansas City
- Washington University School of Medicine, St Louis
Mengambil pesertaFasa 2
Sehingga umur 21 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06064097Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- Saint Francis Medical Center, Cape Girardeau
- Lake Regional Hospital, Osage Beach
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06532279Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.